company background image
3183

WIN-Partners TSE:3183 Stock Report

Last Price

JP¥970.00

Market Cap

JP¥27.6b

7D

-4.0%

1Y

3.0%

Updated

02 Dec, 2022

Data

Company Financials
3183 fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance1/6
Financial Health6/6
Dividends3/6

3183 Stock Overview

WIN-Partners Co., Ltd., through its subsidiaries, distributes medical devices to medical institutions primarily in Japan.

WIN-Partners Co., Ltd. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for WIN-Partners
Historical stock prices
Current Share PriceJP¥970.00
52 Week HighJP¥1,091.00
52 Week LowJP¥924.00
Beta0.69
1 Month Change0.21%
3 Month Change-0.31%
1 Year Change2.97%
3 Year Change-34.37%
5 Year Change-27.12%
Change since IPO152.60%

Recent News & Updates

Recent updates

Shareholder Returns

3183JP HealthcareJP Market
7D-4.0%-4.9%-3.0%
1Y3.0%-3.3%-1.1%

Return vs Industry: 3183 exceeded the JP Healthcare industry which returned -0.8% over the past year.

Return vs Market: 3183 exceeded the JP Market which returned 0.4% over the past year.

Price Volatility

Is 3183's price volatile compared to industry and market?
3183 volatility
3183 Average Weekly Movement2.7%
Healthcare Industry Average Movement4.0%
Market Average Movement3.6%
10% most volatile stocks in JP Market7.4%
10% least volatile stocks in JP Market2.0%

Stable Share Price: 3183 is less volatile than 75% of JP stocks over the past 3 months, typically moving +/- 3% a week.

Volatility Over Time: 3183's weekly volatility (3%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1973548Hideumi Akizawahttps://www.win-partners.co.jp

WIN-Partners Co., Ltd., through its subsidiaries, distributes medical devices to medical institutions primarily in Japan. The company offers percutaneous transluminal coronary angioplasty balloon catheters, drug-eluting stents, and intravascular ultrasound catheters; pacemakers, implantable cardioverter defibrillators, cardiac resynchronization therapy defibrillators, and ablation catheters; and stent grafts, transcatheter heart valves, and mechanical heart valves. It also provides peripheral vascular stents, carotid artery stents, and embolic coils; and insulin pumps, as well as continuous glucose monitoring and magnetic resonance imaging equipment.

WIN-Partners Co., Ltd. Fundamentals Summary

How do WIN-Partners's earnings and revenue compare to its market cap?
3183 fundamental statistics
Market CapJP¥27.57b
Earnings (TTM)JP¥1.77b
Revenue (TTM)JP¥68.86b

15.5x

P/E Ratio

0.4x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
3183 income statement (TTM)
RevenueJP¥68.86b
Cost of RevenueJP¥60.21b
Gross ProfitJP¥8.65b
Other ExpensesJP¥6.88b
EarningsJP¥1.77b

Last Reported Earnings

Sep 30, 2022

Next Earnings Date

n/a

Earnings per share (EPS)62.39
Gross Margin12.57%
Net Profit Margin2.57%
Debt/Equity Ratio0.0%

How did 3183 perform over the long term?

See historical performance and comparison

Dividends

3.7%

Current Dividend Yield

56%

Payout Ratio

Does 3183 pay a reliable dividends?

See 3183 dividend history and benchmarks
When do you need to buy 3183 by to receive an upcoming dividend?
WIN-Partners dividend dates
Ex Dividend DateMar 30 2023
Dividend Pay DateJun 29 2023
Days until Ex dividend117 days
Days until Dividend pay date208 days

Does 3183 pay a reliable dividends?

See 3183 dividend history and benchmarks